Skip to main content

Table 2 Comparison of clinical parameters of metabolic syndrome at baseline and after HBD nutritional intervention 1

From: C677T gene polymorphism of MTHFR and metabolic syndrome: response to dietary intervention

Parameters

Baseline

Week 12

Total (n = 44)

T (−) (n = 20)

T (+) (n = 24)

Total (n = 44)

T (−) (n = 20)

T (+) (n = 24)

Waist (cm)

111.83 ± 11.65

106.06 ± 10.63

116.17 ± 10.80d

103.50 ± 13.07a

97.50 ± 12.74b

108.00 ± 11.87c

SBP (mmHg)

131.67 ± 12.96

135.56 ± 13.33

128.75 ± 12.43

121.05 ± 10.12a

119.67 ± 12.54b

122.08 ± 10.33

DBP (mmHg)

84.33 ± 9.45

84.44 ± 11.30

84.25 ± 8.32

75.48 ± 6.10a

75.56 ± 7.26

75.42 ± 5.42c

Fasting Glucose (mg/dl)

109.68 ± 22.33

115.33 ± 25.72

104.60 ± 18.66d

97.24 ± 7.83

93.57. ± 7.74b

99.80 ± 7.16e

HDL-C (mg/dl)

44.88 ± 11.67

46.59 ± 11.79

43.55 ± 9.58

47.40 ± 15.50

49.15 ± 7.30

46.22 ± 10.78

Triglycerides (mg/dl)

171.11 ± 71.49

164.33 ± 64.31

177.90 ± 79.50d

166.47 ± 64.94

142.62 ± 59.04b

173.57 ± 63.28

  1. 1All values are mean ± SD. SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL-C: HDL cholesterol.
  2. aReflects the significance of the differences between total population at baseline vs total population at week 12 determined with an independent t test (p ≤ 0.05).
  3. bReflects the significance of the differences between T(−) carrier at baseline vs T(−) carrier at week 12 determined with an independent t test (p ≤ 0.05).
  4. cReflects the significance of the differences between T(+) carrier at baseline vs T(+) carrier at week 12 determined with an independent t test (p ≤ 0.05).
  5. dReflects the significance of the differences between T(−) carrier at baseline vs T(+) carrier at baseline determined with an independent t test (p ≤ 0.05).
  6. eReflects the significance of the differences between T(−) carrier at week 12 vs T(+) carrier at week 12 determined with an independent t test (p ≤ 0.05).